Market research
NYXH.BR Nyxoah S.A
BR EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 143M
- P/E ratio
- Not available
- Analyst target
- 5.3
- Dividend yield
- Not available
- Beta
- 0.95
Profile
Company facts
- Exchange
- BR
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- BE0974358906
- Market cap
- 143M
- P/E ratio
- Not available
- Analyst target
- 5.3
- Dividend yield
- Not available
- Beta
- 0.95
About
About Nyxoah S.A
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the NYXH.BR discussion.
5 years, 5 months ago
Nyxoah S.A is currently in a long term uptrend where the price is trading 30.6% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Based on the above factors, Nyxoah S.A gets an overall score of 2/5.